Mammography Screening in Elderly Women
Elderly women should continue mammography screening as long as they are in good health with a life expectancy of at least 10 years, regardless of chronological age. 1
Age-Based Screening Framework
Women Age 75 and Older
- No upper age limit exists for stopping mammography screening - the American Cancer Society explicitly does not set a stopping age for breast cancer screening 1
- Women aged 75+ in good health with expected longevity of 10 or more years should continue mammography screening 1
- More than one-third of all breast cancer deaths annually are attributable to women diagnosed after age 70, making continued screening potentially beneficial for healthy older women 1
Screening Frequency for Older Women
- Women aged 55+ should transition to biennial (every 2 years) screening or may continue annual screening based on personal preference 1
- Biennial screening provides adequate mortality benefit with fewer false-positive results in postmenopausal women 1
- Annual screening did not confer the same prognostic advantage in postmenopausal women compared to premenopausal women, except for those currently using menopausal hormone therapy 1
Life Expectancy Assessment
Clinicians must use mortality indices that incorporate age, comorbidities, and functional status when applying clinical judgment about longevity 1
When to Continue Screening
- Life expectancy >10 years: Continue mammography screening 1, 2
- Good overall health status with minimal comorbidities 1
When to Stop Screening
- Life expectancy <5 years: Discontinue routine mammography 3
- Life expectancy 5-10 years: Consider discontinuation, engage in shared decision-making 3
- Severe comorbidities that limit life expectancy 2
Evidence Supporting Continued Screening
- Breast cancer risk increases with age - age is the major risk factor for both developing and dying from breast cancer 4
- Modeling studies estimate 2 fewer breast cancer deaths per 1,000 women in their 70s who continue biennial screening for 10 years instead of stopping at age 69 4
- Observational studies favor extending screening to older women with >10 years life expectancy 4
Potential Harms in Older Women
- False-positive results occur in approximately 200 per 1,000 women screened over 10 years, leading to additional imaging and anxiety 4
- Overdiagnosis affects approximately 13 per 1,000 women screened over 10 years - detecting cancers that would not have become clinically significant 4
- The benefit of screening diminishes toward end of life when life expectancy is limited 5
Critical Pitfall to Avoid
Do not continue screening mammography when life expectancy is less than 10 years - the American College of Physicians explicitly recommends avoiding screening tests in this scenario 2. A concerning 28.5% of older breast cancer survivors received mammography during their last year of life, representing inappropriate overuse 5.
Practical Implementation
Assess the following factors to determine continuation:
- Functional status: Can the patient perform activities of daily living independently? 1
- Comorbidity burden: Use validated indices like the Charlson Comorbidity Index 1
- Patient preferences: Discuss whether potential benefits outweigh harms based on individual values 1
- Recent hormonal exposures: High bone mass or obesity are more predictive of late-life breast cancer than distant hormonal factors 4